High Point’s vTv Therapeutics Inc. has received the U.S. Food and Drug Administration designation as a Breakthrough Therapy for its TTP399 oral supplement treating type 1 diabetes and psoriasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback